Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview
Overview
This paper provides an overview of pharmacological interventions for pediatric obsessive-compulsive disorder, noting that selective serotonin reuptake inhibitors are the initial approach while clomipramine is limited by tolerability. It discusses antipsychotic augmentation and glutamate modulating agents as options for treatment-resistant cases, emphasizing caution regarding side effects. The resource is intended to outline the evidence supporting these medication strategies for children and adolescents.
- ID
0560b8c7ee8146df- Source org
- PubMed Central
- Author
- Aarya K Rajalakshmi (Massachusetts General Hospital), Aditya K S Pawar (Massachusetts General Hospital), Raman Baweja (Penn State Milton S. Hershey Medical Center)
- Published
- 2026-03-06
- OA status
- diamond
- DOI
- 10.5409/wjcp.v15.i1.114315
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 0
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-21T15:52:31.592259+00:00
Cite this entry
BibTeX
@article{allodium:0560b8c7ee8146df,
title = {Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview},
author = {Aarya K Rajalakshmi and Aditya K S Pawar and Raman Baweja},
year = {2026},
journal = {PubMed Central},
doi = {10.5409/wjcp.v15.i1.114315},
url = {https://doi.org/10.5409/wjcp.v15.i1.114315}
}RIS
TY - JOUR TI - Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview AU - Rajalakshmi, Aarya K AU - Pawar, Aditya K S AU - Baweja, Raman PY - 2026 PB - PubMed Central DO - 10.5409/wjcp.v15.i1.114315 UR - https://doi.org/10.5409/wjcp.v15.i1.114315 ER -
APA
Rajalakshmi, A. K., Pawar, A. K. S., & Baweja, R. (2026). Pharmacological treatment of obsessive-compulsive disorder in children and adolescents: An overview. PubMed Central. https://doi.org/10.5409/wjcp.v15.i1.114315
Related entries
- Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive–compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial
- Predictors Associated With Improved Cognitive-Behavioral Therapy Outcome in Pediatric Obsessive-Compulsive Disorder
- Closing the Gap for Children with OCD: A Staged-Care Model of Cognitive Behavioural Therapy with Exposure and Response Prevention
- Internet-Delivered Cognitive Behavior Therapy for Adolescents with Obsessive-Compulsive Disorder: An Open Trial
- Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders
- Family-based cognitive behavioral therapy versus family-based psychoeducation and relaxation training for obsessive-compulsive disorder in children and adolescents: a randomized clinical trial (TECTO)
- Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials
- Online CBT Versus Standard CBT for Pediatric Obsessive-Compulsive Disorder
- Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial
- A Preliminary Study of D-Cycloserine Augmentation of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder